Inventor · disambiguated record
Nicole Harriott
Also filed as: HARRIOTT NICOLE
13 granted patents·7 pending applications·32 citations·filing 2010–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0195US9714246B2[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Jul 25, 2017·22 cites·4 claims
- 0280US11040970B2VMAT2 inhibitor compounds and compositions thereofNEUROCRINE BIOSCIENCES INC·Filed 2018·Granted Jun 22, 2021·2 cites·29 claims
- 0380US11033539B2Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseasesNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Jun 15, 2021·2 cites·17 claims
- 0475US9988382B2[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Jun 5, 2018·1 cites·20 claims
- 0574US11718618B2Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitorsNEUROCRINE BIOSCIENCES INC·Filed 2023·Granted Aug 8, 2023·0 cites·28 claims
- 0674US8822471B2Compounds, pharmaceutical compositions and uses thereofNOSSE BERND·Filed 2012·Granted Sep 2, 2014·4 cites·6 claims
- 0770US2024010647A1SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORSNEUROCRINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0867US11053242B2[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Jul 6, 2021·0 cites·20 claims
- 0965US2025333413A1SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORSNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1059US8293729B2Compounds, pharmaceutical composition and methods relating theretoDYCK BRIAN·Filed 2010·Granted Oct 23, 2012·1 cites·20 claims
- 1159US2021338653A1N-[2-(1 -benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1 -carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseasesNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1259US2018273533A1[9,10-dimethoxy-3-(2-methylpropyl)-1h,2h,3h,4h,6h,7h,11bh-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1352US2025092022A1Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1447US2014045823A1N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereofNOSSE BERND·Filed 2013·Application pending·0 cites
- 1546US9926308B2N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereofBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 27, 2018·0 cites·13 claims
- 1645US2023129359A1Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1744US12486250B2Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 2, 2025·0 cites·2 claims
- 1843US9469631B2N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereofBOEHRINGER INGELHEIM INT·Filed 2013·Granted Oct 18, 2016·0 cites·11 claims
- 1943US8927726B2N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereofHIMMELSBACH FRANK·Filed 2013·Granted Jan 6, 2015·0 cites·11 claims
- 2039US8921398B2N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereofHECKEL ARMIN·Filed 2012·Granted Dec 30, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Nicole Harriott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →